Eli Lilly’s Alzheimer’s disease drug is approved by the US FDA
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s early-stage Alzheimer’s disease treatment, making it the second treatment to slow the progression of the brain-loss-causing disease to be made available to patients in the United States.
POPULAR POSTS
Thousands under evacuation orders in California due to wildfires
November 8, 2024
EU scientists say 2024 will be the hottest year on record
November 8, 2024
LIVE STREAM